

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular extravasation (GO:0045123) | 8.07484050 |
| 2 | N-acetylneuraminate metabolic process (GO:0006054) | 6.90592480 |
| 3 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 6.76726739 |
| 4 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.71172719 |
| 5 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.45808359 |
| 6 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 5.35277155 |
| 7 | regulation of chemokine biosynthetic process (GO:0045073) | 5.29942447 |
| 8 | amino sugar catabolic process (GO:0046348) | 5.26093618 |
| 9 | centriole replication (GO:0007099) | 5.15678160 |
| 10 | positive regulation of histone deacetylation (GO:0031065) | 4.81815846 |
| 11 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.66685447 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.63952027 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.39283022 |
| 14 | negative regulation of cell killing (GO:0031342) | 4.39283022 |
| 15 | microglial cell activation (GO:0001774) | 4.28677298 |
| 16 | negative regulation of interleukin-2 production (GO:0032703) | 4.28504177 |
| 17 | T cell migration (GO:0072678) | 4.16728001 |
| 18 | negative T cell selection (GO:0043383) | 4.15326821 |
| 19 | negative thymic T cell selection (GO:0045060) | 4.11096331 |
| 20 | positive regulation of protein deacetylation (GO:0090312) | 4.07558662 |
| 21 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.98974170 |
| 22 | regulation of growth of symbiont in host (GO:0044126) | 3.98974170 |
| 23 | negative regulation of growth of symbiont in host (GO:0044130) | 3.98974170 |
| 24 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.98974170 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.98390313 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 3.97284701 |
| 27 | neutrophil mediated immunity (GO:0002446) | 3.96888196 |
| 28 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.87265922 |
| 29 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.73773900 |
| 30 | N-acetylglucosamine metabolic process (GO:0006044) | 3.66343455 |
| 31 | centriole assembly (GO:0098534) | 3.57619447 |
| 32 | interferon-gamma production (GO:0032609) | 3.56858145 |
| 33 | tolerance induction (GO:0002507) | 3.55370337 |
| 34 | leukocyte aggregation (GO:0070486) | 3.53463675 |
| 35 | macrophage chemotaxis (GO:0048246) | 3.52637893 |
| 36 | negative regulation of phagocytosis (GO:0050765) | 3.51508541 |
| 37 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50910480 |
| 38 | signal complex assembly (GO:0007172) | 3.48383776 |
| 39 | negative regulation of stress fiber assembly (GO:0051497) | 3.45999586 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.43892019 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.42468574 |
| 42 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.38387344 |
| 43 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.35957063 |
| 44 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.35957063 |
| 45 | necroptotic process (GO:0070266) | 3.31271329 |
| 46 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.25191957 |
| 47 | cellular response to interleukin-15 (GO:0071350) | 3.24719602 |
| 48 | mast cell activation (GO:0045576) | 3.22929913 |
| 49 | leukocyte degranulation (GO:0043299) | 3.22011381 |
| 50 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.20763126 |
| 51 | macrophage activation (GO:0042116) | 3.20430873 |
| 52 | cellular response to cadmium ion (GO:0071276) | 3.17190345 |
| 53 | organelle membrane fusion (GO:0090174) | 3.15348080 |
| 54 | response to interleukin-15 (GO:0070672) | 3.09644431 |
| 55 | induction of positive chemotaxis (GO:0050930) | 3.08890936 |
| 56 | myeloid leukocyte mediated immunity (GO:0002444) | 3.07111506 |
| 57 | cytokinetic process (GO:0032506) | 3.06740973 |
| 58 | positive regulation of isotype switching (GO:0045830) | 3.04450751 |
| 59 | base-excision repair, AP site formation (GO:0006285) | 2.97746836 |
| 60 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.97380303 |
| 61 | reactive oxygen species biosynthetic process (GO:1903409) | 2.95474517 |
| 62 | response to peptidoglycan (GO:0032494) | 2.95247569 |
| 63 | response to folic acid (GO:0051593) | 2.95197911 |
| 64 | alpha-beta T cell activation (GO:0046631) | 2.92180088 |
| 65 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.91005688 |
| 66 | cellular defense response (GO:0006968) | 2.90519147 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 2.88885261 |
| 68 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.88764088 |
| 69 | mature B cell differentiation involved in immune response (GO:0002313) | 2.88149043 |
| 70 | respiratory burst (GO:0045730) | 2.87193152 |
| 71 | regulation of interleukin-2 production (GO:0032663) | 2.86747810 |
| 72 | positive regulation of DNA recombination (GO:0045911) | 2.86224468 |
| 73 | programmed necrotic cell death (GO:0097300) | 2.86014393 |
| 74 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.85170948 |
| 75 | mast cell activation involved in immune response (GO:0002279) | 2.85073801 |
| 76 | mast cell degranulation (GO:0043303) | 2.85073801 |
| 77 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.84756884 |
| 78 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.84090295 |
| 79 | positive regulation of interleukin-1 production (GO:0032732) | 2.83817703 |
| 80 | alpha-beta T cell differentiation (GO:0046632) | 2.82843839 |
| 81 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.82151997 |
| 82 | negative regulation of interleukin-12 production (GO:0032695) | 2.81623975 |
| 83 | daunorubicin metabolic process (GO:0044597) | 2.76147524 |
| 84 | polyketide metabolic process (GO:0030638) | 2.76147524 |
| 85 | doxorubicin metabolic process (GO:0044598) | 2.76147524 |
| 86 | negative regulation of T cell mediated immunity (GO:0002710) | 2.75496460 |
| 87 | regulation of necroptotic process (GO:0060544) | 2.75055816 |
| 88 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.73621735 |
| 89 | positive regulation of granulocyte differentiation (GO:0030854) | 2.72608025 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.72264836 |
| 91 | positive regulation of macrophage differentiation (GO:0045651) | 2.70479709 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.64513455 |
| 93 | negative regulation of interleukin-17 production (GO:0032700) | 2.63172266 |
| 94 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62535992 |
| 95 | neutrophil activation (GO:0042119) | 2.61132397 |
| 96 | regulation of interleukin-17 production (GO:0032660) | 2.59869657 |
| 97 | myeloid leukocyte activation (GO:0002274) | 2.59679036 |
| 98 | heme biosynthetic process (GO:0006783) | 2.59571593 |
| 99 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.59228103 |
| 100 | modulation by symbiont of host immune response (GO:0052553) | 2.59228103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.37631663 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.09703290 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.86912763 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.85133898 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.60649404 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02945290 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.83177915 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.78627378 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.76921009 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.76463167 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.56065484 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.52983444 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.49380658 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48910976 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.44359555 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37339725 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.34037067 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.33533136 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28983310 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.28298624 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.24903536 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.20658246 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.14752128 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05001928 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.04612979 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02249685 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.99791442 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94048870 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92319182 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90312081 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.84683233 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78854045 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.76195088 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74839896 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73737795 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70581193 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.69213968 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65435619 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65161490 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62288726 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.59015644 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.58841946 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.57559667 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57210828 |
| 45 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.55882111 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55339121 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53668090 |
| 48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46513550 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45691259 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44445437 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.43464476 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39652544 |
| 53 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39078515 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.38681670 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.37205543 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37085967 |
| 57 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35044529 |
| 58 | MYC_22102868_ChIP-Seq_BL_Human | 1.33724316 |
| 59 | MAF_26560356_Chip-Seq_TH2_Human | 1.33551894 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33033550 |
| 61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30874237 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30414323 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27468874 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27420169 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25347889 |
| 66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.23470725 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22945854 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21573407 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21069101 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19420937 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16186030 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14191124 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13441942 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13227652 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12846961 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11321519 |
| 77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.07340080 |
| 78 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06892202 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05732124 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04535536 |
| 81 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02366796 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01730393 |
| 83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01423786 |
| 84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99326411 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99247846 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97426484 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97027641 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96121790 |
| 89 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93770475 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93280111 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93085556 |
| 92 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89702309 |
| 93 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89589634 |
| 94 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.89571103 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89549467 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89512132 |
| 97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88294847 |
| 98 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.86932249 |
| 99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.86427621 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86115579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 4.85119573 |
| 2 | MP0003436_decreased_susceptibility_to | 3.13059665 |
| 3 | MP0005365_abnormal_bile_salt | 2.83579673 |
| 4 | MP0006082_CNS_inflammation | 2.77885269 |
| 5 | MP0003252_abnormal_bile_duct | 2.75308327 |
| 6 | MP0003724_increased_susceptibility_to | 2.60730044 |
| 7 | MP0002419_abnormal_innate_immunity | 2.49695836 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.45245502 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.38695271 |
| 10 | MP0005671_abnormal_response_to | 2.34363976 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.26616021 |
| 12 | MP0008961_abnormal_basal_metabolism | 2.24695845 |
| 13 | MP0009785_altered_susceptibility_to | 2.24535235 |
| 14 | MP0005025_abnormal_response_to | 2.19001644 |
| 15 | MP0004043_abnormal_pH_regulation | 2.16727672 |
| 16 | MP0003195_calcinosis | 2.14108429 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.13062563 |
| 18 | MP0001800_abnormal_humoral_immune | 2.12089310 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.09643102 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.07179009 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.06467207 |
| 22 | MP0001819_abnormal_immune_cell | 2.02952332 |
| 23 | MP0000685_abnormal_immune_system | 1.93375783 |
| 24 | MP0002723_abnormal_immune_serum | 1.92885668 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 1.92554917 |
| 26 | MP0005387_immune_system_phenotype | 1.91945909 |
| 27 | MP0001790_abnormal_immune_system | 1.91945909 |
| 28 | MP0005360_urolithiasis | 1.88625585 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.85224887 |
| 30 | MP0004947_skin_inflammation | 1.82285843 |
| 31 | MP0001853_heart_inflammation | 1.79483308 |
| 32 | MP0002405_respiratory_system_inflammati | 1.79355596 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.75257419 |
| 34 | MP0005451_abnormal_body_composition | 1.73880103 |
| 35 | MP0008058_abnormal_DNA_repair | 1.73290776 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.69742353 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.66611425 |
| 38 | MP0002398_abnormal_bone_marrow | 1.64745109 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.62877550 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.61455805 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.57334104 |
| 42 | MP0000716_abnormal_immune_system | 1.56211497 |
| 43 | MP0000703_abnormal_thymus_morphology | 1.52229862 |
| 44 | MP0005670_abnormal_white_adipose | 1.51055600 |
| 45 | MP0002722_abnormal_immune_system | 1.47682641 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.47267257 |
| 47 | MP0003828_pulmonary_edema | 1.44847329 |
| 48 | MP0002139_abnormal_hepatobiliary_system | 1.39002059 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.36095558 |
| 50 | MP0005310_abnormal_salivary_gland | 1.35240275 |
| 51 | MP0001873_stomach_inflammation | 1.34778073 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.34766770 |
| 53 | MP0009764_decreased_sensitivity_to | 1.30158921 |
| 54 | MP0000343_altered_response_to | 1.29504225 |
| 55 | MP0003448_altered_tumor_morphology | 1.28322757 |
| 56 | MP0002429_abnormal_blood_cell | 1.27597472 |
| 57 | MP0008875_abnormal_xenobiotic_pharmacok | 1.23237652 |
| 58 | MP0009840_abnormal_foam_cell | 1.23009545 |
| 59 | MP0008469_abnormal_protein_level | 1.18228371 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.13628656 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.13628656 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.13204218 |
| 63 | MP0005164_abnormal_response_to | 1.12402796 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.11238253 |
| 65 | MP0003303_peritoneal_inflammation | 1.10912192 |
| 66 | MP0009115_abnormal_fat_cell | 1.10713215 |
| 67 | MP0003091_abnormal_cell_migration | 1.05535466 |
| 68 | MP0010329_abnormal_lipoprotein_level | 1.05033434 |
| 69 | MP0009763_increased_sensitivity_to | 1.04141734 |
| 70 | MP0004130_abnormal_muscle_cell | 1.03066987 |
| 71 | MP0006054_spinal_hemorrhage | 1.01970890 |
| 72 | MP0009278_abnormal_bone_marrow | 1.00710426 |
| 73 | MP0005166_decreased_susceptibility_to | 0.94797983 |
| 74 | MP0008057_abnormal_DNA_replication | 0.92790828 |
| 75 | MP0004510_myositis | 0.90030478 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.89834588 |
| 77 | MP0003866_abnormal_defecation | 0.89255543 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.86923876 |
| 79 | MP0002396_abnormal_hematopoietic_system | 0.86513826 |
| 80 | MP0000858_altered_metastatic_potential | 0.84526606 |
| 81 | MP0002132_abnormal_respiratory_system | 0.84182139 |
| 82 | MP0000003_abnormal_adipose_tissue | 0.84024990 |
| 83 | MP0000249_abnormal_blood_vessel | 0.83203600 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.82930128 |
| 85 | MP0002933_joint_inflammation | 0.82734287 |
| 86 | MP0003786_premature_aging | 0.80552417 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.79972230 |
| 88 | MP0008007_abnormal_cellular_replicative | 0.79753635 |
| 89 | MP0009643_abnormal_urine_homeostasis | 0.78960280 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.78466795 |
| 91 | MP0005058_abnormal_lysosome_morphology | 0.77200277 |
| 92 | MP0003959_abnormal_lean_body | 0.76740440 |
| 93 | MP0002332_abnormal_exercise_endurance | 0.74858380 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.72859750 |
| 95 | MP0005334_abnormal_fat_pad | 0.71645084 |
| 96 | MP0005023_abnormal_wound_healing | 0.71119708 |
| 97 | MP0005266_abnormal_metabolism | 0.70800556 |
| 98 | MP0003075_altered_response_to | 0.70702212 |
| 99 | MP0005410_abnormal_fertilization | 0.70560218 |
| 100 | MP0000609_abnormal_liver_physiology | 0.69243966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.75331372 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.69300698 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.37849781 |
| 4 | Myositis (HP:0100614) | 4.04305339 |
| 5 | T lymphocytopenia (HP:0005403) | 3.53067027 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.43658202 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.37934231 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.37430936 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.37238292 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 3.28952739 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 3.28032547 |
| 12 | Obstructive lung disease (HP:0006536) | 3.28032547 |
| 13 | Thrombocytosis (HP:0001894) | 3.26359182 |
| 14 | Abnormality of the prostate (HP:0008775) | 3.22181708 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.18522510 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.18522510 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.18522510 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.15879731 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.15487346 |
| 20 | Optic neuritis (HP:0100653) | 3.15487346 |
| 21 | Severe combined immunodeficiency (HP:0004430) | 3.12967292 |
| 22 | Chest pain (HP:0100749) | 3.10387901 |
| 23 | Abnormality of T cells (HP:0002843) | 3.05841300 |
| 24 | Orchitis (HP:0100796) | 3.04417241 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.00519097 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 2.96153094 |
| 27 | Combined immunodeficiency (HP:0005387) | 2.89307125 |
| 28 | Pulmonary infiltrates (HP:0002113) | 2.88403275 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 2.87278530 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 2.86668056 |
| 31 | Pustule (HP:0200039) | 2.79238172 |
| 32 | Myocardial infarction (HP:0001658) | 2.76551726 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 2.73808659 |
| 34 | Abnormality of T cell physiology (HP:0011840) | 2.70733252 |
| 35 | Papillary thyroid carcinoma (HP:0002895) | 2.69022102 |
| 36 | Gangrene (HP:0100758) | 2.62334345 |
| 37 | Epistaxis (HP:0000421) | 2.56251480 |
| 38 | Arterial thrombosis (HP:0004420) | 2.56141880 |
| 39 | Meningitis (HP:0001287) | 2.53975014 |
| 40 | Increased cerebral lipofuscin (HP:0011813) | 2.53281091 |
| 41 | Exertional dyspnea (HP:0002875) | 2.52006658 |
| 42 | Recurrent skin infections (HP:0001581) | 2.49307091 |
| 43 | Hemoptysis (HP:0002105) | 2.48896613 |
| 44 | Generalized hyperpigmentation (HP:0007440) | 2.42282723 |
| 45 | Glomerulopathy (HP:0100820) | 2.42134742 |
| 46 | Hepatosplenomegaly (HP:0001433) | 2.42011640 |
| 47 | Cutaneous photosensitivity (HP:0000992) | 2.40846877 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38611167 |
| 49 | Increased serum ferritin (HP:0003281) | 2.37949552 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.37855047 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.37855047 |
| 52 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.37692069 |
| 53 | Increased hepatocellular lipid droplets (HP:0006565) | 2.37366005 |
| 54 | Encephalitis (HP:0002383) | 2.37240356 |
| 55 | Vasculitis (HP:0002633) | 2.36985650 |
| 56 | Flat occiput (HP:0005469) | 2.36335492 |
| 57 | Subacute progressive viral hepatitis (HP:0006572) | 2.27449550 |
| 58 | Renal Fanconi syndrome (HP:0001994) | 2.25494830 |
| 59 | Anorexia (HP:0002039) | 2.22874817 |
| 60 | Gingival bleeding (HP:0000225) | 2.18437345 |
| 61 | Metabolic alkalosis (HP:0200114) | 2.18021878 |
| 62 | Recurrent viral infections (HP:0004429) | 2.17814646 |
| 63 | Xanthomatosis (HP:0000991) | 2.17545161 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.15798604 |
| 65 | Global brain atrophy (HP:0002283) | 2.15192444 |
| 66 | Skin rash (HP:0000988) | 2.14304215 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.13453832 |
| 68 | Porencephaly (HP:0002132) | 2.13190437 |
| 69 | Loss of speech (HP:0002371) | 2.12543007 |
| 70 | Polyneuropathy (HP:0001271) | 2.12437985 |
| 71 | Leukocytosis (HP:0001974) | 2.10750279 |
| 72 | Cerebral hemorrhage (HP:0001342) | 2.10629649 |
| 73 | Thrombophlebitis (HP:0004418) | 2.09526359 |
| 74 | Mediastinal lymphadenopathy (HP:0100721) | 2.09475005 |
| 75 | Pulmonary embolism (HP:0002204) | 2.08743204 |
| 76 | Episodic fever (HP:0001954) | 2.07725247 |
| 77 | Neonatal respiratory distress (HP:0002643) | 2.07410600 |
| 78 | Fatigue (HP:0012378) | 2.04195074 |
| 79 | Urticaria (HP:0001025) | 2.03406816 |
| 80 | Keratoconjunctivitis sicca (HP:0001097) | 2.02844921 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.02358115 |
| 82 | Hyponatremia (HP:0002902) | 2.01873436 |
| 83 | Prostate neoplasm (HP:0100787) | 2.01798547 |
| 84 | Hypokalemic alkalosis (HP:0001949) | 2.01453836 |
| 85 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.00208919 |
| 86 | Lipid accumulation in hepatocytes (HP:0006561) | 1.99930191 |
| 87 | IgG deficiency (HP:0004315) | 1.99013237 |
| 88 | Granulocytopenia (HP:0001913) | 1.98682224 |
| 89 | Increased CSF protein (HP:0002922) | 1.97710809 |
| 90 | Viral hepatitis (HP:0006562) | 1.97202082 |
| 91 | Increased intramyocellular lipid droplets (HP:0012240) | 1.95535532 |
| 92 | Hypokinesia (HP:0002375) | 1.94858331 |
| 93 | Keratoconjunctivitis (HP:0001096) | 1.93356262 |
| 94 | Gastrointestinal inflammation (HP:0004386) | 1.93315597 |
| 95 | Respiratory difficulties (HP:0002880) | 1.89767815 |
| 96 | Eosinophilia (HP:0001880) | 1.89512514 |
| 97 | Fair hair (HP:0002286) | 1.88971650 |
| 98 | Prolonged bleeding time (HP:0003010) | 1.87702004 |
| 99 | Abnormality of eosinophils (HP:0001879) | 1.87516965 |
| 100 | Petechiae (HP:0000967) | 1.87149770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CCNB1 | 4.79178038 |
| 2 | CAMKK2 | 4.51810589 |
| 3 | TESK2 | 4.02381756 |
| 4 | NEK2 | 4.01202221 |
| 5 | SIK3 | 3.96371345 |
| 6 | TXK | 3.27218190 |
| 7 | TRIM28 | 3.26826859 |
| 8 | IRAK3 | 3.25856444 |
| 9 | CAMK1D | 2.75617838 |
| 10 | ERN1 | 2.49910330 |
| 11 | ZAP70 | 2.30629343 |
| 12 | TAF1 | 2.24686982 |
| 13 | MAP4K1 | 2.16741959 |
| 14 | MAP3K3 | 2.15325494 |
| 15 | RIPK4 | 1.77160954 |
| 16 | CAMKK1 | 1.72370029 |
| 17 | ARAF | 1.65150514 |
| 18 | SMG1 | 1.60671634 |
| 19 | JAK3 | 1.59982873 |
| 20 | VRK2 | 1.56193068 |
| 21 | TESK1 | 1.54385918 |
| 22 | MAP3K13 | 1.52933653 |
| 23 | CAMK1G | 1.52296025 |
| 24 | CSK | 1.46632455 |
| 25 | PRPF4B | 1.43105481 |
| 26 | KSR1 | 1.38665771 |
| 27 | CHUK | 1.35295433 |
| 28 | ITK | 1.23748541 |
| 29 | SYK | 1.20054813 |
| 30 | LRRK2 | 1.17960018 |
| 31 | TEC | 1.17409412 |
| 32 | JAK1 | 1.13400438 |
| 33 | TYK2 | 1.11930312 |
| 34 | MAP2K3 | 1.07842866 |
| 35 | FES | 1.03517671 |
| 36 | TAOK3 | 0.98176624 |
| 37 | HCK | 0.97293146 |
| 38 | BCR | 0.95817521 |
| 39 | IKBKE | 0.95546547 |
| 40 | MAP3K14 | 0.95433485 |
| 41 | MAP3K7 | 0.95278815 |
| 42 | PIK3CG | 0.93670829 |
| 43 | NUAK1 | 0.91926185 |
| 44 | TBK1 | 0.90970723 |
| 45 | IKBKB | 0.90429911 |
| 46 | LIMK1 | 0.88936703 |
| 47 | GRK6 | 0.86040003 |
| 48 | RAF1 | 0.82233574 |
| 49 | STK10 | 0.81295255 |
| 50 | MOS | 0.79412607 |
| 51 | BLK | 0.78820829 |
| 52 | BTK | 0.78041239 |
| 53 | LCK | 0.76529202 |
| 54 | IRAK4 | 0.73663495 |
| 55 | BMPR2 | 0.68930566 |
| 56 | TGFBR2 | 0.68767111 |
| 57 | BRSK2 | 0.66860320 |
| 58 | PDGFRB | 0.66428747 |
| 59 | KSR2 | 0.65429561 |
| 60 | TAOK2 | 0.64251443 |
| 61 | PIM1 | 0.63209889 |
| 62 | ERBB4 | 0.62607659 |
| 63 | PASK | 0.62354840 |
| 64 | MST4 | 0.61482725 |
| 65 | MATK | 0.59392365 |
| 66 | BRAF | 0.57991958 |
| 67 | FGR | 0.57546845 |
| 68 | MELK | 0.50646276 |
| 69 | PDK2 | 0.50289676 |
| 70 | LYN | 0.48840768 |
| 71 | CAMK1 | 0.45977314 |
| 72 | DDR2 | 0.45633212 |
| 73 | PTK2B | 0.45442816 |
| 74 | CSF1R | 0.43841946 |
| 75 | CLK1 | 0.43530455 |
| 76 | IRAK2 | 0.40175481 |
| 77 | GRK7 | 0.40163651 |
| 78 | KIT | 0.39107962 |
| 79 | PRKAA2 | 0.37345664 |
| 80 | MAP3K9 | 0.34799704 |
| 81 | PRKCQ | 0.34007004 |
| 82 | MAPK4 | 0.32641965 |
| 83 | TRPM7 | 0.32127720 |
| 84 | BMX | 0.31346199 |
| 85 | MARK2 | 0.31161459 |
| 86 | PIM2 | 0.29301593 |
| 87 | TTN | 0.27734244 |
| 88 | EIF2AK2 | 0.27328966 |
| 89 | MAP3K2 | 0.26809031 |
| 90 | MAPKAPK2 | 0.26118439 |
| 91 | IGF1R | 0.24259235 |
| 92 | MAP3K1 | 0.23748668 |
| 93 | CDK9 | 0.23402976 |
| 94 | CAMK4 | 0.23207396 |
| 95 | PAK4 | 0.22731113 |
| 96 | ADRBK2 | 0.22695364 |
| 97 | HIPK2 | 0.21378498 |
| 98 | MAP3K8 | 0.21321060 |
| 99 | ABL2 | 0.20513201 |
| 100 | YES1 | 0.18315016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.98592626 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.69971071 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49745865 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.47059949 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.38563898 |
| 6 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.35241556 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.34500119 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.24719538 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.93257813 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.90532860 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85011056 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.81428748 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77798134 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.77525375 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76546613 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.75932121 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.74442806 |
| 18 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.74154975 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69344081 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.68537192 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.66122965 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.63528043 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54944242 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.54096924 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.49968632 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49932264 |
| 27 | Thyroid cancer_Homo sapiens_hsa05216 | 1.47745904 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.47055523 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.45529020 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.36078322 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35623763 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32982753 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.32799392 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32455198 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31736395 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.30900906 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27292226 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.25042802 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.24608672 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24028245 |
| 41 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.22754553 |
| 42 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.19596741 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.18928928 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17993925 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15544325 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.14342831 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12578717 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.11552795 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.07653933 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99884709 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99679492 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.98045129 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96837573 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95857581 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94468109 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93094774 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92879945 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91118255 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87454474 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87007523 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85135170 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84893752 |
| 63 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83990978 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81037908 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80136989 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.79351651 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79286833 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.77508097 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76309406 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75124102 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.75041884 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.71778531 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70081630 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68455400 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62925806 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61920292 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61675679 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60699962 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58654755 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55966198 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51609068 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50825653 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50617385 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48749512 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45812472 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44883740 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42597398 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.41324431 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40960693 |
| 90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39178481 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35789573 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35043974 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.34319376 |
| 94 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.33405502 |
| 95 | Base excision repair_Homo sapiens_hsa03410 | 0.30201330 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29845017 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29294495 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28988779 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26660458 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26179618 |

